TVRD position history
The shares of Tvardi Therapeutics (TVRD) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q2: 43,225 shares, $1M, <0.01% of portfolio, New
- 2025 Q3: 86,450 shares, $3.4M, 0.01% of portfolio, Add +100.0%
- 2025 Q4: 43,225 shares, $186K, <0.01% of portfolio, Reduce −50.0%
- 2026 Q1: 21,438 shares, $68K, <0.01% of portfolio, Reduce −50.4%
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|